Pond Technologies Holdings Inc. · TSXV:POND

Pond Technologies — Investor Presentation (April 2021)

24 slides from Pond Technologies's investor presentation, April 2021

  1. Slide 1: Pond Technologies April 2021

    TSX.V: POND, OTCQB: PNDHF April 2021

  2. Slide 2: Advisory

    ADVISORY This presentation contains forward-looking statements and information (collectively referred to as "forward-looking information") within the meaning of applicable securities laws about Pond's projections, targets and estimates based on certain assumptions disclosed in this advisory and in o

  3. Slide 3: Pond: Overview

    POND: OVERVIEW Climate Change due to CO2 is a reality Carbon Capture and Storage (CCS) from industrial emissions or directly from the air is very expensive. The absence of a sustainable ROI has hindered widespread commercial adoption of CCS

  4. Slide 4: Pond: Hungry for CO2

    POND: HUNGRY FOR CO2 Pond transforms CO2 from any source into valuable products Disruptive technology that naturally sequesters Carbon to profitably address global challenges of: • Climate Change • Nutrition • Disease

  5. Slide 5: PondTech: Technology Platform

    PONDTECH: TECHNOLOGY PLATFORM Pond provides optimal growth conditions for algae, producing sustainable protein, nutraceuticals, and more Pond Algae Platform Algae is expected to be the future of plant-based feeds for livestock; it is high in protein, with a complete amino-acid profile, sustainably p

  6. Slide 6: Pond: How Pond Technology Works

    POND: HOW POND TECHNOLOGY WORKS Pond transforms CO2 from any source into valuable algae products Driving the future of an algae based bio-economy

  7. Slide 7: Pond: Controlled Growth Outperforms

    POND: CONTROLLED GROWTH OUTPERFORMS Pond boosts the productivity of micro-algae beyond the power of nature Current Competitors: Pond‘s Growth Platform: Outdoor methods: • Controls total growth • Algae grows in top few environment including light, inches only- gases and temperature in enclosed photo-

  8. Slide 8: Market | Growing Opportunities

    MARKET | GROWING OPPORTUNITIES The market for algae is a multibillion-dollar industry, and our patented technology can capture all market segments NUTRACEUTICALS FOOD COLOURANTS Target Market: >$10 billion Target Market: >$2 billion CAGR: 10% – 20% CAGR: 4% – 7%, accelerating Price per tonne: $10,00

  9. Slide 9: Pond: Business Units

    POND: BUSINESS UNITS Across multiple sectors to fully exploit our platform technology POND TECH (PRODUCT SALES, LICENSING AND ROYALTIES) Pond Tech is engaged in the sale and licensing of its CO2 abatement technology to project developers, funders, engineering companies, and others in partnership wit

  10. Slide 10: Pond Tech

    POND TECH pendtech

  11. Slide 11: PondTech - Algae for Humans and Animals using Industrial Emissions

    PondTech - Algae for Humans and Animals using Industrial Emissions • Pond’s proprietary growth system uses Photobioreactors to optimize growth conditions to maximize Algae will be the future of plant-based algae output. feeds for livestock; it’s high in protein, • Protected by an extensive with a co

  12. Slide 12: Pond Tech: License Extensive IP Portfolio

    POND TECH: LICENSE EXTENSIVE IP PORTFOLIO Pond has a global patent portfolio covering its platform and algae production >9 Patents Pending Active US Patents Algae Platform Protection 9 US patents in process, with over 3x Modulation patents protect 24 International Patents in process more patents fil

  13. Slide 13: PondTech: Modular Photobioreactor for Export

    PONDTECH: MODULAR PHOTOBIOREACTOR FOR EXPORT PondTech sale of PBR’s allows companies the ability to inexpensively test the technology and algae strains against their emissions, de-risking new projects globally and shortening Pond’s sales cycle • Fully integrated modular facility for testing input ga

  14. Slide 14: Pond Tech: Licensing Strategy

    POND TECH: LICENSING STRATEGY Pond has engaged with project developers and funders to advance the agenda Europe: • UK-based Remedi!ate** Licensee $500,000 upfront license fee revenue in 2021 with $2,000,000 minimum annual revenue ongoing North America • US-based BioCarbN and others are developing pr

  15. Slide 15: Pond Naturals

    POND NATURALS pendtech

  16. Slide 16: Pond Naturals: Fast Tracking Revenues

    POND NATURALS: FAST TRACKING REVENUES Pond Naturals is a revenue producing division with existing commercial production and extraction of astaxanthin located in Agassiz B.C. FACILITY: ASTAXANTHIN PLANT • Technology improvements underway to deliver expanded capacity to produce and extract over $500,0

  17. Slide 17: Pond Naturals: Products and Revenue

    POND NATURALS: PRODUCTS AND REVENUE • Pond Naturals grows and sells Astaxanthin at its BC facility and sells ingredients • Patent pending all-natural extraction process at Pond’s BC facility, yields a premium value astaxanthin, nature’s highest anti-oxidant • Ingredients include: microalgae, antioxi

  18. Slide 18: Pond Biotech

    POND BIOTECH pendtech

  19. Slide 19: Problem for Bio-Pharma: Grow Quality Proteins at Scale

    9 Problem for Bio-Pharma: Grow Quality Proteins at scale for Diagnostics and Therapeutics • Current production of complex proteins in Yeast, Bacteria and Mammalian Cell Lines. This can lead to quality issues and high waste. • The current system for cultivating these proteins is expensive compared to

  20. Slide 20: Pond Platform Solution for Bio-Pharma

    10 Pond Platform Solution for Bio-Pharma • Controlled growth environment for genetically modified algae that can express proteins for diagnostics and therapeutics. • Consistent quality due to contained growth system. • Proven scalability. • Proper protein folding. • Less expensive.

  21. Slide 21: Pond Biotech: Bio-Pharma Division

    POND BIOTECH :BIO-PHARMA DIVISION The initial business focus is on the development and growth of genetically modified algae strains that can express valuable proteins for use in diagnostic and therapeutic applications. The division was created to become a CMO for bio-tech and pharmaceutical companie

  22. Slide 22: Pond: Leadership

    POND: LEADERSHIP A strong team to realize our vision GRANT SMITH THOMAS MASNEY EMIDIO DI PIETRO PETER HOWARD Chief Executive Officer Chief Financial Officer VP, Engineering VP Project Development Executive with 20+ years experience in Worked with Goldman Sachs & GE in Comprehensive experience in hig

  23. Slide 23: Cap Table: March 2021

    CAP TABLE: March 2021 Shares / Warrants Number Common Shares Issued: 42.3 million Reserved for Regenurex Acquisition: 4.6 million Common Shares Issued and Reserved 46.9 million (Insiders control 8.9 Million shares ~19%) Warrants: $0.45 / share Exp. March 2023 10 million Warrants: $0.25 / share Exp.

  24. Slide 24: Pond: Contact Information

    POND: CONTACT INFORMATION Pond Technologies Holdings Inc. Head Office 250 Shields Court, Unit 8 Markham, Ontario L3R 9W7 Tel. +1 (416) 287-3835 g.smith@pondtech.com Please see the Advisory for references and assumptions

Pond Technologies Holdings — Investor Presentation (April 2021) on 6ix